EM1-mAb DuoBody (Genmab)

N/A

Report date: 2026/03/26 20:00:17

Base Information

Drug NameEM1-mAb DuoBody (Genmab)

Drug Alias NameEM1-mAb DuoBodyAb-957

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibodyBiologics > T cell engagers

Mechanisms of ActionEpidermal growth factor receptor erbB1 modulatorsHepatocyte growth factor receptor modulators

TargetsEpidermal growth factor receptor erbB1Hepatocyte growth factor receptor

Therapy Area/IndicationsAutoimmune Diseases

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesJohnson & Johnson Innovative Medicine Genmab A/S

China Registration ClassN/A

Develop Information

Active CompaniesJohnson & Johnson Innovative Medicine Genmab A/S

Inactive CompaniesN/A

Active IndicationsAutoimmune Diseases

Inactive IndicationsN/A

Other Information

ATC CodeN/A